{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:38:00Z","timestamp":1794854280480,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J014257\/1"],"award-info":[{"award-number":["MR\/J014257\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0900421"],"award-info":[{"award-number":["G0900421"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G116\/143"],"award-info":[{"award-number":["G116\/143"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M003108\/1"],"award-info":[{"award-number":["MR\/M003108\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["CSUB19166"],"award-info":[{"award-number":["CSUB19166"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J01107X\/1"],"award-info":[{"award-number":["MR\/J01107X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-Network 2012-6-ICE"],"award-info":[{"award-number":["ARUK-Network 2012-6-ICE"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-PG2014-1946"],"award-info":[{"award-number":["ARUK-PG2014-1946"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/J020990\/1"],"award-info":[{"award-number":["EP\/J020990\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/M02533\/1, EP\/L016478\/1, EP\/H046410\/1, EP\/J020990\/1, EP\/K005278"],"award-info":[{"award-number":["EP\/M02533\/1, EP\/L016478\/1, EP\/H046410\/1, EP\/J020990\/1, EP\/K005278"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is increasing interest in improving understanding of the timing and nature of early neurodegeneration in Alzheimer\u2019s disease (AD) and developing methods to measure this in vivo. Autosomal dominant familial Alzheimer\u2019s disease (FAD) provides the opportunity for investigation of presymptomatic change. We assessed early microstructural breakdown of cortical grey matter in FAD with diffusion-weighted MRI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Diffusion-weighted and T1-weighed MRI were acquired in 38 FAD mutation carriers (17 symptomatic, 21 presymptomatic) and 39 controls. Mean diffusivity (MD) was calculated for six cortical regions previously identified as being particularly vulnerable to FAD-related neurodegeneration. Linear regression compared MD between symptomatic and presymptomatic carriers and controls, adjusting for age and sex. Spearman coefficients assessed associations between cortical MD and cortical thickness. Spearman coefficients also assessed associations between cortical MD and estimated years to\/from onset (EYO). Across mutation carriers, linear regression assessed associations between MD and EYO, adjusting for cortical thickness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with controls, cortical MD was higher in symptomatic mutation carriers (mean\u2009\u00b1\u2009SD CDR\u2009=\u20090.88\u2009\u00b1\u20090.39) for all six regions (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In late presymptomatic carriers (within 8.1\u2009years of predicted symptom onset), MD was higher in the precuneus (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and inferior parietal cortex (<jats:italic>p<\/jats:italic>\u2009=\u20090.003) compared with controls. Across all presymptomatic carriers, MD in the precuneus correlated with EYO (<jats:italic>p<\/jats:italic>\u2009=\u20090.04). Across all mutation carriers, there was strong evidence (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) of association between MD and cortical thickness in all regions except entorhinal cortex. After adjusting for cortical thickness, there remained an association (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in mutation carriers between MD and EYO in all regions except entorhinal cortex.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Cortical MD measurement detects microstructural breakdown in presymptomatic FAD and correlates with proximity to symptom onset independently of cortical thickness. Cortical MD may thus be a feasible biomarker of early AD-related neurodegeneration, offering additional\/complementary information to conventional MRI measures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-020-00679-2","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:11:58Z","timestamp":1600355518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-9916","authenticated-orcid":false,"given":"Philip S. J.","family":"Weston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivor J. A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Modat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin N.","family":"Rossor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Ourselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"111","key":"679_CR1","doi-asserted-by":"publisher","first-page":"111cm33","DOI":"10.1126\/scitranslmed.3002609","volume":"3","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med. 2011;3(111):111cm33.","journal-title":"Sci Transl Med"},{"issue":"1","key":"679_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, et al. Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3(1):1.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"679_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83(3):253\u201360.","journal-title":"Neurology."},{"issue":"3","key":"679_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19(3):497\u2013510.","journal-title":"Cereb Cortex"},{"issue":"19","key":"679_CR5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1212\/WNL.0000000000003322","volume":"87","author":"PS Weston","year":"2016","unstructured":"Weston PS, Nicholas JM, Lehmann M, Ryan NS, Liang Y, Macpherson K, et al. Presymptomatic cortical thinning in familial Alzheimer disease: a longitudinal MRI study. Neurology. 2016;87(19):2050\u20137.","journal-title":"Neurology."},{"issue":"6","key":"679_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrn1119","volume":"4","author":"D Le Bihan","year":"2003","unstructured":"Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci. 2003;4(6):469\u201380.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"679_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1212\/01.WNL.0000153076.46126.E9","volume":"64","author":"K Kantarci","year":"2005","unstructured":"Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O\u2019Brien PC, et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2005;64(5):902\u20134.","journal-title":"Neurology."},{"issue":"7","key":"679_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jnnp.2009.189639","volume":"81","author":"E Scola","year":"2010","unstructured":"Scola E, Bozzali M, Agosta F, Magnani G, Franceschi M, Sormani MP, et al. A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up. J Neurol Neurosurg Psychiatry. 2010;81(7):798\u2013805.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 7","key":"679_CR9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/brain\/awm102","volume":"130","author":"JM Ringman","year":"2007","unstructured":"Ringman JM, O\u2019Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer\u2019s disease mutations. Brain. 2007;130(Pt 7):1767\u201376.","journal-title":"Brain"},{"issue":"10","key":"679_CR10","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1093\/brain\/awy229","volume":"141","author":"MA Araque Caballero","year":"2018","unstructured":"Araque Caballero MA, Suarez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer\u2019s disease. Brain. 2018;141(10):3065\u201380.","journal-title":"Brain"},{"key":"679_CR11","doi-asserted-by":"publisher","first-page":"101767","DOI":"10.1016\/j.nicl.2019.101767","volume":"22","author":"Q Wang","year":"2019","unstructured":"Wang Q, Wang Y, Liu J, Sutphen CL, Cruchaga C, Blazey T, et al. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer\u2019s disease. NeuroImage Clin. 2019;22:101767.","journal-title":"NeuroImage Clin"},{"key":"679_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-7091-6467-9_11","volume":"53","author":"H Braak","year":"1998","unstructured":"Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer\u2019s disease. J Neural Transm Suppl. 1998;53:127\u201340.","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"679_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neuroimage.2008.10.053","volume":"45","author":"KB Walhovd","year":"2009","unstructured":"Walhovd KB, Fjell AM, Amlien I, Grambaite R, Stenset V, Bjornerud A, et al. Multimodal imaging in mild cognitive impairment: metabolism, morphometry and diffusion of the temporal-parietal memory network. NeuroImage. 2009;45(1):215\u201323.","journal-title":"NeuroImage."},{"issue":"10","key":"679_CR14","doi-asserted-by":"publisher","first-page":"e75115","DOI":"10.1371\/journal.pone.0075115","volume":"8","author":"C Chiapponi","year":"2013","unstructured":"Chiapponi C, Piras F, Piras F, Fagioli S, Caltagirone C, Spalletta G. Cortical grey matter and subcortical white matter brain microstructural changes in schizophrenia are localised and age independent: a case-control diffusion tensor imaging study. PLoS One. 2013;8(10):e75115.","journal-title":"PLoS One"},{"issue":"11","key":"679_CR15","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology."},{"issue":"2","key":"679_CR16","doi-asserted-by":"publisher","first-page":"024003","DOI":"10.1117\/1.JMI.1.2.024003","volume":"1","author":"M Modat","year":"2014","unstructured":"Modat M, Cash DM, Daga P, Winston GP, Duncan JS, Ourselin S. Global image registration using a symmetric block-matching approach. J Med Imaging. 2014;1(2):024003.","journal-title":"J Med Imaging"},{"issue":"7","key":"679_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.media.2014.06.008","volume":"18","author":"P Daga","year":"2014","unstructured":"Daga P, Pendse T, Modat M, White M, Mancini L, Winston GP, et al. Susceptibility artefact correction using dynamic graph cuts: application to neurosurgery. Med Image Anal. 2014;18(7):1132\u201342.","journal-title":"Med Image Anal"},{"issue":"3","key":"679_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12021-016-9297-6","volume":"14","author":"A Melbourne","year":"2016","unstructured":"Melbourne A, Toussaint N, Owen D, Simpson I, Anthopoulos T, De Vita E, et al. NiftyFit: a software package for multi-parametric model-fitting of 4D magnetic resonance imaging data. Neuroinformatics. 2016;14(3):319\u201337.","journal-title":"Neuroinformatics."},{"issue":"1","key":"679_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43\u20136.","journal-title":"Epidemiology."},{"issue":"1","key":"679_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jmri.21231","volume":"27","author":"SE Rose","year":"2008","unstructured":"Rose SE, Janke AL, Chalk JB. Gray and white matter changes in Alzheimer\u2019s disease: a diffusion tensor imaging study. J Magn Reson Imaging. 2008;27(1):20\u20136.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"679_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350.","journal-title":"Lancet Neurol"},{"issue":"1","key":"679_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jalz.2011.11.004","volume":"9","author":"HI Jacobs","year":"2013","unstructured":"Jacobs HI, van Boxtel MP, Gronenschild EH, Uylings HB, Jolles J, Verhey FR. Decreased gray matter diffusivity: a potential early Alzheimer\u2019s disease biomarker? Alzheimer\u2019s Dement. 2013;9(1):93\u20137.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"22","key":"679_CR23","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1212\/WNL.0b013e3181e0f7cf","volume":"74","author":"K Kantarci","year":"2010","unstructured":"Kantarci K, Avula R, Senjem ML, Samikoglu AR, Zhang B, Weigand SD, et al. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology. 2010;74(22):1814\u201321.","journal-title":"Neurology."},{"issue":"3","key":"679_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3233\/JAD-2010-100678","volume":"22","author":"J Fortea","year":"2010","unstructured":"Fortea J, Sala-Llonch R, Bartres-Faz D, Bosch B, Llado A, Bargallo N, et al. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimer\u2019s Dis. 2010;22(3):909\u201322.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"Pt 3","key":"679_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/brain\/awv404","volume":"139","author":"E Rodriguez-Vieitez","year":"2016","unstructured":"Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Scholl M, et al. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease. Brain. 2016;139(Pt 3):922\u201336.","journal-title":"Brain"},{"key":"679_CR26","doi-asserted-by":"crossref","unstructured":"Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, et al. Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease. Neurology. 2020;94(19):e2026\u2013e2036.","DOI":"10.1212\/WNL.0000000000009405"},{"key":"679_CR27","doi-asserted-by":"crossref","unstructured":"Montal V, Vilaplana E, Alcolea D, Pegueroles J, Pasternak O, Gonzalez-Ortiz S, et al. Cortical microstructural changes along the Alzheimer\u2019s disease continuum. Alzheimer\u2019s Dement. 2017;14(3):340\u201351.","DOI":"10.1016\/j.jalz.2017.09.013"},{"issue":"Pt 5","key":"679_CR28","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/brain\/awt065","volume":"136","author":"NS Ryan","year":"2013","unstructured":"Ryan NS, Keihaninejad S, Shakespeare TJ, Lehmann M, Crutch SJ, Malone IB, et al. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer\u2019s disease. Brain. 2013;136(Pt 5):1399\u2013414.","journal-title":"Brain"},{"issue":"7","key":"679_CR29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archneur.60.7.989","volume":"60","author":"RI Scahill","year":"2003","unstructured":"Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol. 2003;60(7):989\u201394.","journal-title":"Arch Neurol"},{"issue":"4","key":"679_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1212\/01.wnl.0000198510.73363.c6","volume":"66","author":"B Benedetti","year":"2006","unstructured":"Benedetti B, Charil A, Rovaris M, Judica E, Valsasina P, Sormani MP, et al. Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI. Neurology. 2006;66(4):535\u20139.","journal-title":"Neurology."},{"issue":"4","key":"679_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/brain\/awz031","volume":"142","author":"I Illan-Gala","year":"2019","unstructured":"Illan-Gala I, Montal V, Borrego-Ecija S, Vilaplana E, Pegueroles J, Alcolea D, et al. Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy. Brain. 2019;142(4):1121\u201333.","journal-title":"Brain"},{"issue":"4","key":"679_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.neuroimage.2005.06.029","volume":"28","author":"MJ Muller","year":"2005","unstructured":"Muller MJ, Greverus D, Dellani PR, Weibrich C, Wille PR, Scheurich A, et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. NeuroImage. 2005;28(4):1033\u201342.","journal-title":"NeuroImage."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00679-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00679-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00679-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:21:42Z","timestamp":1631834502000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00679-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00679-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Queen Square Research Ethics Committee (reference number 11\/LO\/0753) and all participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PSJW, TP, JMN, NT, IJAS, ML, MM, NSR, YL and MNR report no disclosures. JMS has received research funding from AVID Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly), has consulted for Roche Pharmaceuticals and Eli Lilly and serves on a Data Safety Monitoring Committee for Axon Neuroscience SE. SO has received personal compensation for activities and research support from IXICO Ltd. He also received financial support for his research from Siemens Molecular Imaging, MIRADA Medical Solution and GE Healthcare. NCF reports research support from Avid\/Lilly, Biogen, Elan\/Janssen, GE and Roche and has served on a data safety monitoring committee for Biogen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}